ABSTRACT KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] is a newly synthesized class III antiarrhythmic drug and is known to be highly effective against various types of arrhythmias induced by coronary artery ligation, reperfusion, and programmed electrical stimulation. To understand the potential ionic mechanisms, we examined the effects of KCB-328, which encodes the rapidly activating delayed rectifier K ϩ current in cardiac tissues, on human ether-a-go-gorelated gene (HERG) channels expressed in Xenopus oocytes. The amplitudes of steady-state currents and tail currents of HERG were decreased by KCB-328 dose dependently. The decrease became more pronounced at more positive potential, suggesting that the block of HERG by KCB-328 is voltage-dependent. IC 50 values at Ϫ30, Ϫ20, Ϫ10, 0, ϩ10, ϩ20, ϩ30, and ϩ40 mV were 7.6 Ϯ 0.5, 4.8 Ϯ 0.4, 3.2 Ϯ 0.3, 2.1 Ϯ 0.3, 1.7 Ϯ 0.2, 1.4 Ϯ 0.2, 1.3 Ϯ 0.1, and 1.2 Ϯ 0.1 M, respectively. Induction of block depended on depolarization beyond the threshold for channel opening. In addition, time-dependent block developed slowly, with ϭ 1.7 Ϯ 0.3 s (100 M) at 0 mV, and was delayed by a stronger depolarization to ϩ80 mV, at which HERG channel is inactivated. We can conclude that KCB-328 preferentially blocks open (or activated) HERG channels. The block of HERG current might in part explain the underlying ionic mechanism for the antiarrhythmic and proarrhythmic effect of KCB-328.
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The delayed rectifier K ϩ current is critical for repolarization of cardiac action potential. It represents the sum of two components that are kinetically, pharmacologically, and genetically distinct. The faster component, designated I Kr , is blocked selectively by class III methanesulfonanilides such as dofetilide, E-4031, and ibutilide, whereas the slower component I Ks is not (Jurkiewicz and Sanguinetti, 1993; Krafte and Volberg, 1994; Yang et al., 1995) . Selective blocks of I Kr as well as I Ks could be useful therapies for cardiac arrhythmias.
The human ether-a-go-go-related gene, HERG, which is expressed in the heart of mammalian species including humans (Wymore et al., 1997) , encodes the pore-forming subunit of I Kr (Sanguinetti et al., 1995; Wang et al., 1997) . It was shown that channels formed by coexpression of mink-related peptide 1 (MiRP1) and HERG resemble native cardiac I Kr channels (Abbott et al., 1999) . Interestingly, naturally occurring mutations in HERG underlie the chromosome 7-linked inherited long QT syndrome (LQT) Sanguinetti et al., 1995) . Heterologously expressed HERG currents share pharmacological properties with I Kr and are blocked by methanesulfonanilides such as dofetilide and MK-499 (Kiehn et al., 1995; Spector et al., 1996) . I Kr /HERG represents an important target for antiarrhythmic drugs. This work was supported by grants from the Science and Technology Evaluation Planning Institute of Korea (Grant 97-N1-02-02-A) and from the Korea Science and Engineering Foundation (Grant 98-0403-10-01-5).
1 Both authors contributed equally to this study. ABBREVIATIONS: I Kr , the rapidly activating outward rectifier K ϩ current; APD, action potential duration; HERG, human ether-a-go-go-related gene; I K , the delayed rectifier K ϩ current; I Ks , the slowly activating outward rectifier K ϩ current; KCB-328, 1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride; LQT syndrome, long QT syndrome; MiRP1, mink-related peptide 1; E-4031, 1-[2-(6-methyl-2-pyridyl)-ethyl]-4-(4-methylsulfonylaminobenzoyl)piperidine; KCNE2, the potassium channel gene encoding MinK-related peptide-1; 2, 3, 
The therapeutic potential of class III antiarrhythmic drugs, however, is limited by their capability of inducing an excessive prolongation of action potentials, which can cause acquired LQT and sudden cardiac death (Sanguinetti and Keating, 1997) .
Recently, a novel class III antiarrhythmic agent, 1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride (KCB-328; Fig. 1 ) was synthesized by C & C Research Laboratories (Kyunggi-do, Korea) (Kim et al., 1999) . In the initial studies, KCB-328 prolonged the action potential duration (APD) without reverse frequency dependence (Lee et al., 1998) and inhibited outward tail current in guinea pig cardiomyocytes, suggesting that I K blocking is one of the possible mechanisms for the class III activity of KCB-328 (Lee et al., 1996) . Furthermore, KCB-328 showed powerful antiarrhythmic effects in a dog in vivo arrhythmia model (Xue et al., 1998a) . Therefore, it can be assumed that KCB-328 may prolong action potential duration and exert antiarrhythmic effects by inhibiting the HERG channel. To examine this possibility, we examined the effect of KCB-328 on the HERG current expressed in Xenopus oocytes. We found that KCB-328 blocks primarily the activated (open) HERG channels in a time-, voltage-, and concentration-dependent manner.
Materials and Methods

Expression of HERG and Current Recording in Xenopus
Oocytes. Stage V to VI oocytes were collected from the anesthetized female Xenopus laevis (Carolina Biological Supply Co., Burlington, NC) through a small abdominal incision. The follicular membranes were then removed after collagenase treatment (type II; SigmaAldrich, St. Louis, MO). cRNA of HERG was synthesized from linearized cDNA using an in vitro transcription kit (Ambion, Austin, TX) and stored in 10 mM Tris-HCl, pH 7.4, at Ϫ80°C. Oocytes were then injected with 50 nl of cRNA (1 ng nl Ϫ1 ). After injection, oocytes were cultured at 18°C in solution containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 5 mM HEPES, pH 7.55, supplemented with 5 mM pyruvate and 50 g ml Ϫ1 gentamicin sulfonate. Currents were recorded 2 to 4 days after injection. Water-injected oocytes showed insignificant amounts of currents from endogenous channels.
HERG currents were measured at room temperature (21-23°C) using a two-electrode voltage-clamp amplifier (OC-725B; Warner Instruments, Hamden, CT). Stimulation and data acquisition were controlled with Digidata 1200B and pClamp 6.0.3 (Axon Instruments, Union City, CA). Electrodes were filled with 3 M KCl and had a resistance of 1 to 2 M⍀ for current-passing electrodes and a resistance of 4 to 6 M⍀ for voltage-recording electrodes. Oocytes were then bathed in Ringer's solution containing 120 mM NaCl, 2.5 mM KCl, 1.1 mM CaCl 2 , 1.0 mM EGTA, 1 mM MgCl 2 , 10 mM HEPES, pH 7.2.
Pulse Protocols and Analysis. The standard protocol to obtain current-voltage relationships and activation curves consisted of depolarizing steps in 10-mV increments from Ϫ70 to ϩ40 mV for 4 s from a holding potential of Ϫ80 mV and repolarization to Ϫ40 mV for 6 s. Steps were repeated at 60-s intervals. The steady-state currents were obtained at the end of the 4-s depolarizations. Further details are given in the text and figure legends.
The voltage dependence of HERG current activation was determined for each oocyte by fitting peak values of tail current (I tail ) versus test potential (V t ) to the Boltzmann function:
where I tail max is maximum tail current, V 1/2 is the voltage at which 50% of the channels are activated, and k is the slope factor. Concentration-response relationships for KCB-328-induced HERG block were fitted to a Hill equation.
the drug concentration, n the Hill coefficient, and IC 50 the concentration necessary for 50% block. The data were expressed as mean Ϯ S.E.M. All data were compared by Student's t test. Drugs. KCB-328 was kindly provided by C & C Research Laboratories (Kyunggi-do, Korea) and was dissolved in dimethyl sulfoxide.
Results
To examine whether KCB-328 blocks HERG, we studied the effect of KCB-328 on HERG current expressed in Xeno- Fig. 2 . Effect of KCB-328 on HERG current expressed in Xenopus oocytes. A, traces of HERG current were recorded before and after exposure to 1 M KCB-328 for 10 min and 15 min after washout of the drug. Voltage protocol consisted of depolarizing steps in 10-mV increments from Ϫ70 to ϩ40 mV for 4 s from a holding potential of Ϫ80 mV and repolarization to Ϫ40 mV for 6 s. Steps were repeated at 60-s intervals. B and C, current-voltage plots of steady-state (B) and peak tail currents (C) from six oocytes in the absence or presence of 1 M KCB-328 and after washout of the drug. The currents were normalized to the maximum steady-state (B) or peak tail currents (C) in the absence of KCB-328 in each oocyte. Each point with vertical bar denotes the mean Ϯ S.E.M. Fig. 1 . Chemical structure of the agent, KCB-328.
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at ASPET Journals on April 9, 2017 jpet.aspetjournals.org pus oocytes. Figure 2A shows a typical HERG current family elicited by depolarizing voltage steps ranging from Ϫ70 to ϩ40 mV with 10-mV increments, with a return potential of Ϫ40 mV. In Xenopus oocytes injected with the cRNA-encoding HERG, slowly rising currents were apparent on depolarizations. The relationship between the current at the end of the pulse and membrane potential showed the characteristic bell-shaped relationship of HERG, reflecting inward rectification at more positive potentials (Fig. 2B) . Upon returning to repolarization at Ϫ40 mV, the large, slowly deactivating tail currents characteristic of HERG were observed. Tail current amplitude increased with depolarizing step from Ϫ40 to 0 mV and was then superimposed on further depolarizing steps to ϩ 40 mV. KCB-328 (1 M) inhibited both the outward and tail currents ( Fig. 2A) . The current-voltage relationship of the steady-state current at the end of the depolarizing step and peak tail current are depicted in Fig. 2 , B and C, respectively, before and after exposure to 1 M KCB-328 (n ϭ 6). For control conditions, the threshold for activating HERG current was close to Ϫ40 mV, and full activation was obtained at a voltage near ϩ10 mV. In the presence of 1 M KCB-328, outward current at depolarizing step and tail current amplitude were reduced compared with the control. Steady-state current and peak tail current were recovered to more than 95% of the control level within 10 min after washout of the drug (Fig. 2, B and C) .
Drugs that block ion channels often alter the voltage dependence of channel kinetics. Therefore, we analyzed the voltage dependence of activation of the peak amplitude of the decaying tail currents in the absence or presence of KCB-328 (1 M) (Fig. 2C) . The voltage dependence of HERG activation was determined using 4-s test pulses to potentials ranging from Ϫ70 to ϩ40 mV. Peak amplitudes of tail currents were measured at Ϫ40 mV, plotted as a function of test potential, and fitted with a Boltzmann function. In this case, we used the data at the partial range (from Ϫ70 to ϩ10 mV) because the relative current decreased at more positive potential. In the control experiment, the activation curve had a midpoint of Ϫ20.5 Ϯ 1.1 mV and a slope factor of 6.6 Ϯ 0.4 mV (n ϭ 6), which is similar to values reported by other investigators (Wang et al., 1997) . Addition of KCB-328 (1 M) resulted in a decrease of the tail current amplitudes. However, there was no significant change in voltage dependence of the activation curve (n ϭ 6, data not shown). When the concentration of KCB-328 was increased, the amplitude of the peak tail current was decreased, indicating that the maximum conductance of HERG channels is decreased by KCB-328. It was also noticed that in the presence of KCB-328, tail current did not reach the steady-state level but declined at more positive potentials, indicating that the blocking effect is more pronounced at positive potential.
This result may suggest that the effect of KCB-328 is voltage-dependent, and we tested this possibility in Fig. 3 . We compared the decrease of tail current by KCB-328 at different potentials and found a higher degree of block at more positive voltages (Fig. 3, A and B) . At Ϫ30 mV, KCB-328 (3 M) reduced peak tail current amplitude by 41 Ϯ 5% (n ϭ 6, P Ͻ 0.01), whereas at ϩ30 mV, it reduced peak tail current amplitude by 74 Ϯ 3% (n ϭ 6, P Ͻ 0.01). Doseresponse relationships obtained at Ϫ30, 0, and ϩ30 mV are demonstrated in Fig. 3C . Data were fitted with a Hill equation, and IC 50 values for KCB-328 block of HERG current were obtained at different potentials. IC 50 values at Ϫ30, Ϫ20, Ϫ10, 0, ϩ10, ϩ20, ϩ30, and ϩ40 mV were 7.6 Ϯ 0.5, 4.8 Ϯ 0.4, 3.2 Ϯ 0.3, 2.1 Ϯ 0.3, 1.7 Ϯ 0.2, 1.4 Ϯ 0.2, 1.3 Ϯ 0.1, and 1.2 Ϯ 0.1 M, respectively (n ϭ 6). These data indicate that KCB-328 block of HERG current is voltage-dependent.
To determine possible mechanisms for KCB-328 block of HERG current, the extent of KCB-328 block was measured on repetitive depolarizations (Fig. 4) . After the control currents were measured, the membrane potential was held at Ϫ80 mV to keep the channel in the closed conformation during wash-in of 3 M KCB-328. The first depolarization to 0 mV after 10 min at Ϫ80 mV yielded little reduction in current (by 17.0 Ϯ 4.6% of the amplitude of peak tail currents before KCB-328, n ϭ 6). Subsequently, block developed on a currents were recorded at Ϫ40 mV. The magnitude of the decrease of the tail currents indicates that the blocking effect is larger at ϩ30 mV. Calibration bars are 0.5 A in height and 2 s in length. B, voltagedependent block of HERG current by KCB-328 (3 M). The amplitude of the peak tail current evoked by a repolarizing pulse of Ϫ40 mV in the presence of KCB-328 (3 M), normalized to control at each test potential, is plotted as a function of test potentials. The extent of HERG block by KCB-328 (3 M) was increased at a more positive voltage. Data are averaged from six oocytes. C, concentration dependence of KCB-328 block at different membrane potentials (Ϫ30, 0 and ϩ30 mV). The amplitudes of the peak tail currents at the repolarizing pulse of Ϫ40 mV following the test pulse to Ϫ30, 0, or ϩ30 mV were normalized to the maximum current obtained in control, and plotted against KCB-328 concentrations. Data were fitted with a Hill equation. Each point with vertical bars represents mean Ϯ S.E.M., and each data point was obtained from six oocytes. pulse-by-pulse basis (30-s interval), requiring an additional 20 pulses for 10 min to achieve steady-state block. These results indicate that HERG block of KCB-328 requires the channel activation.
To directly test whether channel activation is required for the slowly developing block by KCB-328, the onset of openchannel block by a high concentration of KCB-328 (100 M) was assessed using a single 20-s pulse to 0 mV (Fig. 5) . The oocyte was held at Ϫ80 mV for 10 min during exposure to 100 M KCB-328. During the first depolarizing step in the presence of KCB-328, the current was initially activated as in the control but subsequently displayed a time-dependent decline with a time constant of 1.6 s. With this paradigm, the time constant for onset of block averaged 1.7 Ϯ 0.3 s (n ϭ 6) for 100 M KCB-328. The complete suppression of the subsequent tail current confirmed that all HERG current had been blocked during this single depolarizing step (Fig. 5A) . To evaluate whether stronger depolarizations would enhance block, we clamped the membrane potential at ϩ80 mV (Fig.  5B) . Interestingly, unlike the time-dependent decline of current at 0 mV in the presence of 100 M KCB-328, the current at ϩ 80 mV declined initially and then plateaued. It resumed its exponential time course when the potential was restored to 0 mV. This apparent delay of block was quantified by the horizontal shift of the exponential fits (Fig. 5B) . The average delay was 1.8 Ϯ 0.6 s (n ϭ 6) with the 2-s intervening depolarization. These results indicate that the strong inactivation of the channel prevented HERG block of KCB-328. Figure 6 illustrates the frequency-independent block of HERG currents by KCB-328. Twenty repetitive 100-ms depolarizing pulses of ϩ10 mV from a holding potential of Ϫ80 mV were applied at three different frequencies of 1, 3, and 10 Hz. In the presence of KCB-328 (10 M), the peak amplitudes of tail currents measured at Ϫ40 mV decreased by 56 Ϯ 5% (n ϭ 3), 57 Ϯ 3%, and 59 Ϯ 6% (n ϭ 3) at 1, 3, and 10 Hz, respectively, in a frequency-independent manner.
Discussion
We have shown that KCB-328 blocks HERG current expressed in Xenopus oocytes. KCB-328 has been demonstrated to be highly effective against a variety of arrhythmias in various animals (Xue et al., 1998a,b) . It also prolonged APD and inhibited I K (Lee et al., 1998) . It is well known that heterologously expressed HERG currents share pharmacological and biophysical properties with I Kr (Kiehn et al., 1995; Sanguinetti et al., 1995; Spector et al., 1996; Wang et al., 1997) . The characteristics of the current recorded in the present study correspond to HERG current: slow current activation at negative potentials, large, long-lasting tail currents on repolarization, strong inward rectification and sensitivity to class III methanesulfonanilides such as MK-499 and dofetilide. Considering all of these, KCB-328 may induce APD prolongation through block of HERG as do class III methanesulfonanilides such as dofetilide and MK-499 do (Carmeliet, 1992 ; Snyders and Chaudhary, 1996; Spector et Fig. 4 . Pulse-dependent development of HERG block with KCB-328 (3 M). A, size of peak tail current evoked by voltage steps to 0 mV. After switching to 3 M KCB-328, the oocyte was held at Ϫ80 mV for 10 min to keep the channel in the closed conformation. A series of steps (4 s at 0 mV, 6 s at Ϫ40 mV) was then applied at 30-s intervals. Each point with vertical bars represents mean Ϯ S.E.M. from five oocytes. B, superimposed current traces evoked by voltage steps to 0 mV before exposure (open circle), after exposure to 3 M KCB-328 for 10 min at Ϫ80 mV (solid circle), and after 20 repetitive depolarizing pulses (4 s at 0 mV, 6 s at Ϫ40 mV) in the presence of KCB-328 (solid triangle).
Fig. 5.
Time-dependent block during a depolarization with 100 M KCB-328. A, after the control trace was obtained, the oocyte was held at Ϫ80 mV for 10 min while KCB-328 (100 M) was allowed to equilibrate. During the first step in the presence of KCB-328 (100 M), the HERG current activated initially as in the control. The exponential fit to the subsequent decline is superimposed on the tracing (solid line). Note that the tail current was completely suppressed. B, delay in block development by depolarization to ϩ80 mV. A 100-ms prepulse to ϩ20 mV preceding the sustained depolarization to 0 mV was used to speed up channel opening. After applying a depolarizing step of 0 mV for 2 s, a strong depolarizing pulse to ϩ80 mV was applied for 2 s, which reduced the current of the control, reflecting strong rectification. Interestingly, a strong depolarizing pulse to ϩ80 mV released KCB-328 block. Exponential lines (dotted lines) with the indicated time constants are fitted to the tracing in the presence of KCB-328. It also illustrates the 1.7-s delay in block development induced by the depolarization to ϩ80 mV. , 1996) . The present study is the first to characterize the interaction between KCB-328 and the HERG channels. The major finding of the present study is that KCB-328 blocks primarily the activated (open) HERG channels in a time-, voltage-, and concentration-dependent manner. This finding provides an ionic mechanism for the antiarrhythmic effect of KCB-328. In other words, all of these indicate that HERG is one of targets of KCB-328.
KCB-328 Blocks
To clarify biophysical mechanism of HERG block by KCB-328, we analyzed the effect of KCB-328 on HERG current using various pulse protocols. The results suggest that KCB-328 block preferentially the activated HERG channels. HERG was not significantly blocked before activation because the first depolarizing pulse to 0 mV after holding at Ϫ80 mV for 10 min in the presence of KCB-328 (3 M) reached a peak amplitude of ϳ75% as shown in Fig. 4 . Furthermore, KCB-328-induced HERG block was prevented when the channel was rectified or inactivated at ϩ80 mV (Fig. 5B) . At low concentrations, block subsequently developed in a pulse-dependent manner but time-dependent block was not apparent (Fig. 4) . To directly demonstrate a timedependent blockade during a single depolarization, high concentrations (Ͼ 30 M) of KCB-328 were needed as shown in Fig. 5 . These results provide direct evidence for time-dependent open channel block of KCB-328, although it remains to be determined whether KCB-328 is a pure open-channel blocker of HERG. Additionally, KCB-328-induced block was not frequency-dependent (Fig. 6) , which may be due to a partly irreversible block or slow recovery from block.
Block of KCB-328 was more pronounced at more positive potential and IC 50 of KCB-328 in blocking HERG was significantly different at all potentials examined (Fig. 3) . These results suggest that the block of HERG by KCB-328 is voltage-dependent. However, KCB-328 (IC 50 of 2.1 M) was less potent than dofetilide at 0 mV (IC 50 of 0.3-0.6 M; Kiehn et al., 1996; Ficker et al., 1998) in blocking HERG expressed in Xenopus oocyte. These results indicate that the blockade produced by KCB-328 is similar to that previously reported with dofetilide except the potency (Kiehn et al., 1996; Snyders and Chaudhary, 1996; Ficker et al., 1998) . This may be due to the structural similarity between KCB-328 and dofetilide.
An ideal class III antiarrhythmic agent would selectively prolong the ventricular action potential at increased heart rates. Currently available class III antiarrhythmic agents do not possess this desired rate dependence. Therapeutic potentials of class III antiarrhythmic drugs are limited by their tendency to cause LQT and cardiac sudden death. Methanesulfonanilides of class III antiarrhythmic drugs such as dofetilide, E-4031, ibutilide, and MK-499 selectively act on I Kr and prolong APD (Jurkiewicz and Sanguinetti, 1993; Krafte and Volberg, 1994; Yang et al., 1995) . KCB-328 also prolonged APD and inhibited I K (Lee et al., 1998) . Furthermore, it was shown that KCB-328 suppressed ventricular fibrillation induced by coronary artery ligation and reperfusion, and programmed electrical stimulation-induced ventricular arrhythmias with old myocardial infarction in an intravenous infusion of 0.5 mg/kg/30 min (Xue et al., 1998a) . However, KCB-328 in a similar condition (0.3 mg/kg/30 min) was also reported to induce arrhythmias and intensify proarrhythmic effects of adrenaline, although KCB-328 is weaker than MS-551 in prolonging QT intervals at the same doses (Xue et al., 1998b) . In view of the above, with our result of KCB-328 at a micromolar concentration, we expect that KCB-328 might produce antiarrhythmic and proarrythmic effects through blockade of HERG. The difference in effective concentrations of KCB-328 in our present study from the previous reports (Xue et al., 1998a,b) may have originated from the different experimental condition.
In the present study, we first reported that KCB-328 blocks HERG current in a time-, voltage-, and concentrationdependent manner, which may account for antiarrhythmic effects of KCB-328 (Xue et al., 1998a) as well as for its proarrhythmic effect previously reported (Xue et al., 1998b) . However, there are several limitations in our study. First, we are unable to provide information regarding the detailed structural determinants of drug binding and blocking. Extensive mutational study is required to address this question. Second, our data do not exclude the possibility of closed state-dependent block by KCB-328. Third, the effect of KCB-328 on the channels formed by coexpression of KCNE2 (encoding MiRP1) and HERG should be addressed because HERG channels coassembled with MiRP1 resemble native cardiac I Kr channels (Abbott et al., 1999) . Furthermore, it would be greatly helpful for understanding the mechanisms of the drug actions and developing class III antiarrhythmic drugs if the effect of KCB-328 on action potential and K ϩ current in human cardiac myocytes were examined. Fig. 6 . Frequency-independent block of HERG current by KCB-328. After the oocyte was held at Ϫ80 mV for 20 min during exposure to 10 M KCB-328, the effect of frequency was tested by applying 20 repetitive 100-ms depolarizing pulses of ϩ10 mV from a holding potential of Ϫ80 mV at three different frequencies of 1, 3, and 10 Hz in the presence of KCB-328 (10 M). The peak amplitudes of tail currents measured at Ϫ40 mV at every pulse were normalized by the peak amplitudes of tail current obtained at the first pulse number, and then plotted versus the pulse numbers. Each point with vertical bar denotes the mean Ϯ S.E.M. (n ϭ 3). 
